News Center
Events
AcroCyte Upcoming Events
In early 2026, we will be participating in several premier global events. We would love the opportunity to meet you in person on the road: ·  
May 1,2026
News
Media Spotlight｜AcroCyte at MEDICA 2025
Recognition is encouraging, but the real impact begins after the spotlight.Following AcroCyte Therapeutics’ Runner-up recognition at the MEDICA Start-up C
December 26,2025
Medica 2025
News
Global Sensation! Taiwan's Pride! AcroCyte Therapeutics Wins Runner-Up in MEDICA 2025 Start-up Competition!
【DÜSSELDORF, Germany】With backing from the National Science and Technology Council (NSTC), AcroCyte Therapeutics, Inc. proudly announces a monumental victo
November 19,2025
Read More
Our Mission
Beyond the Lab, Towards Life.

For too long, the road to precision medicine has been steep: traditional cell cultures are time-consuming, difficult to reproduce, and reliance on animal models and 2D cell lines often fails to accurately reflect the true disease environment.

AcroCyte Therapeutics, Inc. is dedicated to overcoming these common laboratory challenges. Through our R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) technology, we have established ourselves as experts in 3D culturing, focused particularly on our industry-leading work with CTC (Circulating Tumor Cell). This groundbreaking technology allows us to successfully culture CTCs from a patient’s blood and create personalized 3D cell culture models from virtually any specimen.

This innovation completely eliminates the need for traditional cell lines and animal testing, enabling scientists to conduct research on a platform that is both more authentic and highly efficient.

Our mission extends far beyond lab breakthroughs.

Through our Onco-REAL™ clinical service, we are empowering patients to access truly personalized treatment plans using their own cells. We believe that by providing more precise and rapid cell culture technology, we can help clinicians make better-informed decisions, ultimately transforming the landscape of cancer care and offering greater hope for every life.

Read More
Our Core Technologies
R³CE® : The Gold Standard in Predictive 3D Cell Models.
R³CE® Technologies
  • Rapid
    Enable exponential cell expansion from diverse clinical samples, faster than ever.
  • Reproducible
    Achieve unparalleled consistency with highly uniform 3D spheroids.
  • Rare Cell
    Successfully culture and expand sample from rare cell. Every sample is too precious to lose.
Slow?
Taking too long to expand enough cells for your critical assays.
Inconsistent?
Frustrated by hydrogel batch-to-batch variations causing unreliable experiments.
Insufficient?
Losing precious data because of low cell counts in your original samples
Applications
For Drug Developers
Accelerate your preclinical drug screening and validation.
For Clinicians
Provide personalized ex vivo drug sensitivity testing for your patients.
For Researchers
Create customized 3D research models that closely mimic real physiological conditions.
Featured Products
An end-to-end platform from basic research tools to clinical diagnostic services.
R³CE® 3D Cell Culture Plate
High-efficiency 3D culture plate designed for robust organoid growth from any cell source.
Our Breakthrough:
R³CE® Unlocks Boundless Application
Various Specimens
Unmatched Versatility: R³CE® reliably cultures and expands cells from every source—from surgical tissue and biopsies to CSF, ascites, and urine.
Purification & Amplification
Specimens cultured on R³CE® rapidly proliferate and aggregate into spheroids, with observed potential for subsequent development into organoids.
Applications in Analysis & Testing
R³CE® empowers researchers to unlock and create advanced assays, including critical functional studies and personalized drug testing.
Ready to Transform Your Research or Clinical Practice?
For Lab Researchers
Accelerate your 3D cell culture model with no hassle.
Request Information
Get detailed service information and a quote.
Explore Partnership
Discuss business and collaboration opportunities.
Privacy Preference Center

1. Who We Are
At AcroCyte Therapeutics Inc. (“AcroCyte”, “we”, “our”), we are committed to maintaining the trust and confidence of all visitors to our website, www.acrocyte.com. We value your privacy and want you to be clear about how we handle your data. In particular, AcroCyte is not in the business of selling, renting, or trading email lists with other companies for marketing purposes. This Privacy Policy outlines when and why we collect personal information, how we use it, the limited conditions under which we may disclose it to others, and how we keep it secure.

2. Information We Collect & How We Use It
Contact Forms & Business Inquiries
When you contact us via the forms on our website (such as the "Contact Us" page), we collect the professional information you provide, including your name, email address, phone number, company name, job title, industry, area of interest, and the content of your inquiry.

  • Purpose: We use this data solely to communicate with you, verify your identity, answer your technical or business questions, and provide information about our products and services relevant to your request.
  • Marketing Communications: We will only send you newsletters, product updates, or promotional materials if you have explicitly opted in by checking the relevant box (e.g., "Yes, I'd like to receive updates about AcroCyte news and breakthroughs"). You may unsubscribe from these communications at any time by clicking the "unsubscribe" link in our emails.

Cookies
We use cookies to support essential website functionality and to provide a better user experience. You can choose to disable or delete cookies at any time through your internet browser settings; however, this may limit your ability to use certain features of our website.

3. Third-Party Services & Data Processors

Google Analytics
We use Google Analytics to collect standard internet log information and details of visitor behavior patterns. This helps us understand website traffic and improve performance. This information is processed in a way that does not identify anyone personally. We do not make, and do not allow Google to make, any attempt to find out the identities of those visiting our website.

Google reCAPTCHA
To protect our website forms from spam and automated abuse, we use the reCAPTCHA service provided by Google. This service analyzes behavior to distinguish between humans and bots. Your use of reCAPTCHA is subject to Google’s Privacy Policy and Terms of Service.

Service Providers
We may share your information with trusted third-party service providers who assist us in operating our website, conducting our business, or serving our users (e.g., email delivery services, CRM systems, or hosting providers), so long as those parties agree to keep this information confidential.

4. International Data Transfers
AcroCyte operates globally with offices in Taiwan and the United States. Please be aware that your personal information may be transferred to, stored, and processed in a country other than the one in which you reside. By providing us with your information, you acknowledge and agree to this transfer, storage, or processing. We take all reasonable steps to ensure that your data is treated securely and in accordance with this policy.

5. Data Retention
We retain your personal information only for as long as is necessary to fulfill the purposes for which it was collected, including for the purposes of satisfying any legal, accounting, or reporting requirements. When data is no longer needed, we will securely delete or anonymize it.

6. Access to Your Personal Information & Your Rights
You have the right to request access to, correction of, or deletion of any personal data that we hold about you. Depending on your jurisdiction (such as under the GDPR), you may also have the right to restrict processing, object to processing, or request data portability. To make such a request, please contact our Privacy Team at [info@acrocyte.com].

7. Changes to Our Privacy Policy
We may update this Privacy Policy from time to time to reflect changes in our practices or for other operational, legal, or regulatory reasons. The most current version will always be available on our website. By continuing to access or use our website after those changes become effective, you agree to be bound by the revised Privacy Policy.

Cookie Notice